Inspire Veterinary Partners, Inc.

NasdaqCM IVP

Inspire Veterinary Partners, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD 4.74

Inspire Veterinary Partners, Inc. Revenue Per Share is USD 4.74 for the Trailing 12 Months (TTM) ending September 30, 2024, a -97.06% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Inspire Veterinary Partners, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 160.90, a 134.13% change year over year.
  • Inspire Veterinary Partners, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 68.73.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
SV Wall Street
NasdaqCM: IVP

Inspire Veterinary Partners, Inc.

CEO Mr. Kimball Carr
IPO Date Aug. 30, 2023
Location United States
Headquarters 780 Lynnhaven Parkway
Employees 156
Sector Consumers Staples
Industries
Description

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.

StockViz Staff

February 4, 2025

Any question? Send us an email